Dataset Information


Enhanced phosphorylation of Nbs1, a member of DNA repair/checkpoint complex Mre11-RAD50-Nbs1, can be targeted to increase the efficacy of imatinib mesylate against BCR/ABL-positive leukemia cells.

ABSTRACT: Nbs1, a member of the Mre11-RAD50-Nbs1 complex, is phosphorylated by ATM, the product of the ataxia-telangiectasia mutated gene and a member of the phosphatidylinositol 3-kinase-related family of serine-threonine kinases, in response to DNA double-strand breaks (DSBs) to regulate DNA damage checkpoints. Here we show that BCR/ABL stimulated Nbs1 expression by induction of c-Myc-dependent transactivation and protection from caspase-dependent degradation. BCR/ABL-related fusion tyrosine kinases (FTKs) such as TEL/JAK2, TEL/PDGFbetaR, TEL/ABL, TEL/TRKC, BCR/FGFR1, and NPM/ALK as well as interleukin 3 (IL-3), granulocyte-macrophage colony-stimulating factor (GM-CSF), and stem cell factor (SCF) also stimulated Nbs1 expression. Enhanced ATM kinase-dependent phosphorylation of Nbs1 on serine 343 (S343) in response to genotoxic treatment was detected in leukemia cells expressing BCR/ABL and other FTKs in comparison to normal counterparts stimulated with IL-3, GM-CSF, and SCF. Expression of Nbs1-S343A mutant disrupted the intra-S-phase checkpoint, decreased homologous recombinational repair (HRR) activity, down-regulated XIAP expression, and sensitized BCR/ABL-positive cells to cytotoxic drugs. Interestingly, inhibition of Nbs1 phosphorylation by S343A mutant enhanced the antileukemia effect of the combination of imatinib and genotoxic agent.


PROVIDER: S-EPMC1924483 | BioStudies | 2007-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2001-01-01 | S-EPMC87245 | BioStudies
2011-01-01 | S-EPMC3032814 | BioStudies
2007-01-01 | S-EPMC3401479 | BioStudies
1000-01-01 | S-EPMC5342526 | BioStudies
2014-01-01 | S-EPMC3969838 | BioStudies
2008-01-01 | S-EPMC2531069 | BioStudies
1000-01-01 | S-EPMC2518897 | BioStudies
2011-01-01 | S-EPMC3295743 | BioStudies
1000-01-01 | S-EPMC2738569 | BioStudies
1000-01-01 | S-EPMC2118591 | BioStudies